Use of anti-TNF-α therapy in Crohn's disease is associated with increased incidence of multiple sclerosis

The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics

(2018) Carlos R Camara-Lemarroy et al.   BRAIN

Anti–Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease

(2018) Inga Peter et al.   JAMA Neurology

Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry)

(2017) Marta Pérez-De-Lis et al.   Expert Opinion On Drug Safety

Multiple sclerosis and inflammatory bowel diseases: a systematic review and meta-analysis

(2016) Maria Kosmidou et al.   JOURNAL OF NEUROLOGY

Hispanic Americans and African Americans with multiple sclerosis have more severe disease course than Caucasian Americans

(2016) Rachel E Ventura et al.   Multiple Sclerosis Journal

Hispanic Americans and African Americans with multiple sclerosis have more severe disease course than Caucasian Americans

(2016) Rachel E Ventura et al.   Multiple Sclerosis Journal

Association between tumour necrosis factor-  inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study

(2015) N. Nyboe Andersen et al.   BMJ-British Medical Journal

Association between tumour necrosis factor-  inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study

(2015) N. Nyboe Andersen et al.   BMJ-British Medical Journal

Brain involvement in patients with inflammatory bowel disease: a voxel-based morphometry and diffusion tensor imaging study

(2014) Anastasia K. Zikou et al.   EUROPEAN RADIOLOGY

Inflammatory bowel disease and demyelination: more than just a coincidence?

(2014) Aristeidis H Katsanos et al.   Expert Review of Clinical Immunology

A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis

(2014) Ruth Ann Marrie et al.   Multiple Sclerosis Journal

Intestinal Barrier Dysfunction Develops at the Onset of Experimental Autoimmune Encephalomyelitis, and Can Be Induced by Adoptive Transfer of Auto-Reactive T Cells

(2014) Mehrnaz Nouri et al.   PLoS One

Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease

(2013) Hélène Zéphir et al.   Multiple Sclerosis Journal

Geographical variation and incidence of inflammatory bowel disease among US women

(2012) Hamed Khalili et al.   GUT

Multiple sclerosis in the context of TNF blockade and inflammatory bowel disease

(2012) N. C. Hare et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

(2011) Stephen Sawcer et al.   NATURE

Monoclonal antibody therapy-associated neurological disorders

(2011) Xavier Bosch et al.   Nature Reviews Neurology

Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review

(2011) María Cruz Fernández-Espartero et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label

(2011) Cándido Díaz-Lagares et al.   ARTHRITIS RESEARCH & THERAPY

Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study

(2010) A. Langer-Gould et al.   Multiple Sclerosis Journal

Cytokines and Cytokine Profiles in Human Autoimmune Diseases and Animal Models of Autoimmunity

(2009) Manfred Kunz et al.   MEDIATORS OF INFLAMMATION

Potential role of Th17 cells in the pathogenesis ofinflammatory bowel disease

(2009) Zhan-Ju Liu et al.   WORLD JOURNAL OF GASTROENTEROLOGY